Preparation and characterization of an electrospun colon-specific delivery system for salmon calcitonin
暂无分享,去创建一个
Chen Li | M. Zong | Hong Wu | K. Feng | Yun-Shan Wei | Peng Wen | Min-hua Zong
[1] Haiying Cui,et al. The antibacterial activity of clove oil/chitosan nanoparticles embedded gelatin nanofibers against Escherichia coli O157:H7 biofilms on cucumber. , 2018, International journal of food microbiology.
[2] Haiying Cui,et al. Plasma-treated poly(ethylene oxide) nanofibers containing tea tree oil/beta-cyclodextrin inclusion complex for antibacterial packaging. , 2018, Carbohydrate polymers.
[3] Haiying Cui,et al. Antibacterial poly(ethylene oxide) electrospun nanofibers containing cinnamon essential oil/beta-cyclodextrin proteoliposomes. , 2017, Carbohydrate polymers.
[4] Haiying Cui,et al. Novel chitosan film embedded with liposome-encapsulated phage for biocontrol of Escherichia coli O157:H7 in beef. , 2017, Carbohydrate polymers.
[5] Haiying Cui,et al. Improving anti-listeria activity of cheese packaging via nanofiber containing nisin-loaded nanoparticles , 2017 .
[6] M. Zong,et al. Encapsulation of fish oil in a coaxial electrospun nanofibrous mat and its properties , 2017 .
[7] Ning Li,et al. Enhancement of the antimicrobial activity of cinnamon essential oil-loaded electrospun nanofilm by the incorporation of lysozyme , 2017 .
[8] K. Aramaki,et al. Charge boosting effect of cholesterol on cationic liposomes , 2016 .
[9] B. Luppi,et al. Microparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycin. , 2016, Carbohydrate polymers.
[10] Peng Wen,et al. Encapsulation of cinnamon essential oil in electrospun nanofibrous film for active food packaging , 2016 .
[11] Xiaoquan Yang,et al. Plant protein-based delivery systems for bioactive ingredients in foods. , 2015, Food & function.
[12] Deng-Guang Yu,et al. Electrospun medicated shellac nanofibers for colon-targeted drug delivery. , 2015, International journal of pharmaceutics.
[13] A. Zidan,et al. Ultrasound effects on brain-targeting mannosylated liposomes: in vitro and blood–brain barrier transport investigations , 2015, Drug design, development and therapy.
[14] M. Fathi,et al. Novel hesperetin loaded nanocarriers for food fortification: Production and characterization , 2013 .
[15] Christopher A. Bonino,et al. Alginate–Polyethylene Oxide Blend Nanofibers and the Role of the Carrier Polymer in Electrospinning , 2013 .
[16] M. Corredig,et al. Incorporation of phytosterols in soy phospholipids nanoliposomes: Encapsulation efficiency and stability , 2012 .
[17] A. Gazzaniga,et al. Oral colon delivery of insulin with the aid of functional adjuvants. , 2012, Advanced drug delivery reviews.
[18] M. Prausnitz,et al. Delivery of salmon calcitonin using a microneedle patch. , 2012, International journal of pharmaceutics.
[19] Eric A. Smith,et al. Effects of cholesterol on phospholipid membranes: inhibition of the interdigitated gel phase of F-DPPC and F-DPPC/DPPC. , 2012, Chemistry and physics of lipids.
[20] A. Kjøniksen,et al. Studies on pectin coating of liposomes for drug delivery. , 2011, Colloids and surfaces. B, Biointerfaces.
[21] R. C. Evangelista,et al. In vitro characterization of coevaporates containing chitosan for colonic drug delivery , 2009 .
[22] Siling Wang,et al. Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. , 2009, International journal of pharmaceutics.
[23] H. Takeuchi,et al. Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[24] J. Chaumeil,et al. L-cysteine encapsulation in liposomes: Effect of phospholipids nature on entrapment efficiency and stability , 2008 .
[25] A. Basit,et al. Mucoadhesion and the gastrointestinal tract. , 2008, Critical reviews in therapeutic drug carrier systems.
[26] S. Oh,et al. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[27] C. Shim,et al. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[28] W. Sułkowski,et al. The influence of temperature, cholesterol content and pH on liposome stability , 2005 .
[29] D. H. Copp,et al. 25 Years of salmon calcitonin: From synthesis to therapeutic use , 1995, Calcified Tissue International.
[30] William A. Lee,et al. The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer , 1994, Pharmaceutical Research.
[31] Jean-Pierre Benoit,et al. Physico-chemical stability of colloidal lipid particles. , 2003, Biomaterials.
[32] Panos Macheras,et al. Analysis of Case II drug transport with radial and axial release from cylinders. , 2003, International journal of pharmaceutics.
[33] Kwangsok Kim,et al. Structure and process relationship of electrospun bioabsorbable nanofiber membranes , 2002 .
[34] R. Ho,et al. Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.
[35] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[36] M I Ugwoke,et al. The biopharmaceutical aspects of nasal mucoadhesive drug delivery , 2001, The Journal of pharmacy and pharmacology.
[37] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] N. Peppas,et al. Transmucosal delivery systems for calcitonin: a review. , 2000, Biomaterials.